Business
Notice of Allowance
Notice of Allowance.
About this update from Eden Research Plc
[{"type":"text","content":"\n \nRNS Number : 5793M Eden Research plc 28 August 2013 \n \n\n28 August 2013\nEden Research Plc\n(\"Eden\" or \"Company\")\n \nNotice of Allowance for Philippines patent\n \nEden Research plc (AIM: EDEN), the AIM listed terpene and encapsulation development company, announces that the Intellectual Property Office of the Philippines has issued a Notice of Allowance for its platform encapsulation technology. \n \nThe patent covers the Company's core technology, specifically \"compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them.\"\n \nThe encapsulation system is owned outright by Eden and is already granted in Europe, New Zealand, Australia, China, Mexico, Singapore and South Africa. The benefit of having the patent formally granted is that it gives the security of full patent protection to existing and prospective licensees in the Philippines.\n \nClive Newitt, Managing Director of Eden comments: \"We are delighted to announce this Notice of Allowance which further strengthens our intellectual property portfolio. The success of our application validates the uniqueness of our technology and its patentability. It also ensures that the commercial products being developed by our partners using our core technology are uniquely positioned in their markets.\" \n \n \n\n\n\n\nEden Research plc \n\n\nwww.edenresearch.com\n\n\n\n\nSir Ben Gill, Chairman\n\n\nTel: 01993 862 761\n\n\n\n\nClive Newitt, Managing Director\n\n\n\n\n\n\n\nAlex Abrey, Chief Financial Officer\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nW H Ireland Limited \n\n\nTel: 0117 945 3471\n\n\n\n\nJohn Wakefield\nMike Coe\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Ltd\n\n\nTel: 020 7933 8780 or [email protected] \n\n\n\n\nPaul McManus (Media Relations)\n\n\nMob: 07980 541 893 \n\n\n\n\nPaul Cornelius (Investor Relations)\n\n\nMob: 07827 879 496\n\n\n\n\n \nNotes:\n \nEden has developed a terpene-based encapsulation technology which uses yeast cells to deliver a slow release of natural compounds for agricultural and non-agricultural uses. \n \nTerpenes are natural compounds which function as defence mechanisms in many plant groups and are released in re...